EMBC
$8.91
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection device...
Recent News
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated
Despite posting healthy earnings, Embecta Corp.'s ( NASDAQ:EMBC ) stock has been quite weak. Our analysis suggests that...
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15
The board of Embecta Corp. ( NASDAQ:EMBC ) has announced that it will pay a dividend of $0.15 per share on the 17th of...
3 Healthcare Stocks Paying the Highest Dividends of 2026
Which of the highest-yielding healthcare stocks are value traps or golden opportunities?
Embecta Q1 Earnings Call Highlights
Embecta (NASDAQ:EMBC) said it is transitioning from a “stand-up” phase of independence to a “seed growth” phase as management works to stabilize its core insulin delivery franchise, expand the portfolio, and build financial flexibility. On the company’s fiscal first-quarter 2026 earnings call, execu
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges
Embecta Corp (EMBC) showcases strong international growth and strategic advancements in GLP-1 collaborations, despite facing pricing pressures in the US market.